Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 3/2015

01-03-2015 | Letter to the Editors

Body weight-based natalizumab treatment in adult patients with multiple sclerosis

Authors: M. Tanaka, M. Kinoshita, J. F. Foley, K. Tanaka, J. Kira, W. M. Carroll

Published in: Journal of Neurology | Issue 3/2015

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870–1880CrossRefPubMed
2.
Hunt D, Giovannoni G (2012) Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring. Pract Neurol 12:25–35CrossRefPubMed
3.
Foley J, Gudesblatt M, Zarif M, Lathi E (2014) Low body weight as a potential surrogate risk factor for progressive multifocal leukoencephalopathy. In: Pulst SM (ed) The 66th Annual Meeting of American Academy of Neurology. Philadelphia, 26 April–3 May, pp P2–P244
4.
Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402–409PubMedCentralCrossRefPubMed
5.
Metadata
Title
Body weight-based natalizumab treatment in adult patients with multiple sclerosis
Authors
M. Tanaka
M. Kinoshita
J. F. Foley
K. Tanaka
J. Kira
W. M. Carroll
Publication date
01-03-2015
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 3/2015
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7655-1

Other articles of this Issue 3/2015

Journal of Neurology 3/2015 Go to the issue

Original Communication

Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction?

Original Communication

Clinical course of primary progressive aphasia: clinical and FDG-PET patterns

Letter to the Editors

Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis

Review

Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis

Letter to the Editors

Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy

Original Communication

Taste function in early stage treated and untreated Parkinson’s disease